U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Idarubicin Hydrochloride Injection
Status: Discontinuation
»Therapeutic Categories: Oncology

Expand all

Teva (New 08/11/2022)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
NDC 0703-4155-11 (10 mg/10 mL (1 mg/mL) 10 mL Single Dose Vial) 08/11/2022 Product is available with an expected supply duration until JUN' 2022. No future production expected for an extended period.
NDC 0703-4156-11 (20 mg/20 mL (1 mg/mL) 20 mL Single Dose Vial) 08/11/2022 Product is available with an expected supply duration until JUL' 2022. No future production expected for an extended period.
NDC 0703-4154-11 (5 mg/5 mL (1 mg/mL) 5 mL Single Dose Vial) 08/11/2022 Product is currently unavailable and no future production expected for an extended period.
Back to Top